This AACR award recognizes outstanding achievements that advance blood cancer research across hematologic malignancies (e.g., leukemia, lymphoma, myeloma), including discoveries with strong scientific and/or translational relevance.
Eligibility Criteria:
- Cancer researchers worldwide may be nominated (academia, industry, government).
- Individual investigators only (institutions/organizations are not eligible).
Funding Details:
- Recognition award within AACR’s Scientific Achievement Awards.
- Self‑nominations prohibited; nomination submitted through AACR’s electronic nomination platform.
- Nomination materials include a structured nomination letter (max 1,000 words) and supporting documentation per AACR instructions.
Deadline:
- June 30, 2026 (nominations open January 1, 2026).
Where to go for further information: